[18F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trial
Abstract Introduction This is a prospective, single-center trial in pediatric patients with sarcoma aiming to evaluate [18F]FDG PET/CT as a tool for early response assessment to neoadjuvant chemotherapy (neo-CTX). Methods Bone or soft tissue sarcoma patients with (1) baseline [18F]FDG PET/CT within...
Main Authors: | Giulia Polverari, Francesco Ceci, Roberto Passera, Jacquelyn Crane, Lin Du, Gang Li, Stefano Fanti, Nicholas Bernthal, Fritz C. Eilber, Martin Allen-Auerbach, Johannes Czernin, Jeremie Calais, Noah Federman |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-10-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-020-00715-0 |
Similar Items
-
MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer
by: Peng Fei Gao, et al.
Published: (2023-01-01) -
A Case of Ewing Sarcoma of the Mandible on 18F-FDG PET/CT
by: Yasukage Takami, et al.
Published: (2020-01-01) -
Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis
by: Xiangji Li, et al.
Published: (2022-12-01) -
Role of F-18 FDG PET/CT in Predicting Response to Neoadjuvant Chemotherapy in Invasive Ductal Breast Cancer
by: Tarik Sengoz, et al.
Published: (2023-04-01) -
Case report: Low-grade myofibroblastic sarcoma resembling lymphoma on 18F-FDG PET/CT
by: Huan Zhang, et al.
Published: (2023-03-01)